TLPH - Talphera EV/EBITDA Multiple

Corporate company logo of Talphera (TLPH)

Talphera, Inc. (TLPH) integrates environmental standards into the creation of resuscitation tools while strictly adhering to bioethical norms. The EV/EBITDA price action stands at 0.00, visualizing the business valuation. Financial stability is supported by the sale of hospital supplies, enabling investment in new developments. Management previously shifted its focus from medical equipment to the production of emergency medications, aiming to expand its market presence.

TLPH Talphera Corporation: Business Value to Operating Income Before Depreciation in the range 11/23/2025 - 11/10/2026

Analytical breakdowns for Talphera, Inc.

- stock price and consensus target price:
Stock Quotes Talphera Corp|TLPH - Price Target Chart
- market capitalization statistics:
Market Capitalization Talphera Corporation|TLPH - Company Buyout Price
- issuer book value statistics:
Net Assets per Single Share Talphera|TLPH - Accounting Value of Company|Market Cap to Net Assets Ratio talphera.com|TLPH - Company Total Assets
- company liabilities and liquidity data:
Debt to Equity Talphera, Inc.|TLPH - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio Talphera|TLPH - Company Cumulative Indebtedness|Debts to Book Capitalization Talphera Corporation|TLPH - Company Long-Term Debts|Company Short-Term Debt Talphera|Quick Liquidity talphera.com
- business earnings and investment ratios data:
TLPH - Profit After Tax|Projected Future Earnings Talphera, Inc.|TLPH - Company Value to Net Income|Forward P/E Multiple Talphera, Inc.|TLPH - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Talphera Corporation|TLPH - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Talphera|TLPH - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months talphera.com|TLPH - Earnings per share increase in current year|Earnings growth forecast for next year Talphera, Inc.
General company analysis:Talphera Corp TLPH
Original product of Talphera Inc

Investors utilize this indicator for comparative asset analysis, as it benchmarks enterprise value (EV) against earnings before interest, taxes, depreciation, and amortization (EBITDA), eliminating the impact of taxes and debt structure. Assessing the efficiency of implementing pain management systems in hospitals via the current EV/EBITDA ratio of Talphera, Inc. (TLPH) determines the extent to which market capitalization is justified by the business's actual ability to generate cash flow.

Competitors of Talphera, Inc.

Gilead Sciences Inc - Enterprise Value to EBITDA Ratio|Cidara - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Novavax, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio curevac.com CVAC|Valneva (VALN) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Vir Biotechnology Inc - Business Value to Operating Income Before Depreciation|Enterprise Value to EBITDA Ratio SIGA|EV/EBITDA Multiple Emergent Bio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Atea Pharmaceuticals (AVIR)|Total Company Value to Operating Income Before Depreciation Ratio invivyd.com|Enanta Pharmaceuticals, Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio INO (Inovio Pharmaceuticals, Inc.)|HilleVax Corp - EV/EBITDA Multiple|KLRS - EV/EBITDA Multiple|dyadic.com (DYAI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|NNVC (NanoViricides) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cocrystal Pharma|Traws Therapeutics - Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple DWTX|QLGN (Qualigen Corp) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ALVR (AlloVir)|VBI Vaccines, Inc. (VBIV) - Company Value to EBITDA|VIRI - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation VXRT (Vaxart, Inc.)